Hayes Christopher G. Insider Trading Activity

Average Profitability
53.25%
Insider Buys Quantity
3
Insider Buys Sum
$61,974.40
Insider Sells Quantity
8
Insider Sells Sum
$511,773.71

Insider Activity of Hayes Christopher G.

Biography of Hayes Christopher G.

No biography is available at this moment.

2025-03-17SaleVerrica Pharmaceuticals Inc.
VRCA
CHIEF LEGAL OFFICER
4,315
0.0047%
$0.65$2,805-12.75%
2024-08-27SaleVerrica Pharmaceuticals Inc.
VRCA
CHIEF LEGAL OFFICER
9,530
0.0223%
$2.46$23,444-72.56%
2024-08-26SaleVerrica Pharmaceuticals Inc.
VRCA
CHIEF LEGAL OFFICER
26,183
0.0635%
$2.66$69,647-73.68%
2024-07-23SaleVerrica Pharmaceuticals Inc.
VRCA
CHIEF LEGAL OFFICER
91
0.0002%
$6.98$635-90.45%
2024-07-22SaleVerrica Pharmaceuticals Inc.
VRCA
CHIEF LEGAL OFFICER
21,649
0.051%
$7.06$152,842-89.85%
2023-11-15SaleVerrica Pharmaceuticals Inc.
VRCA
Chief Legal Officer
11,558
0.0255%
$2.97$34,327+75.08%
2023-11-14SaleVerrica Pharmaceuticals Inc.
VRCA
Chief Legal Officer
22,141
0.0523%
$2.93$64,873+89.42%
2023-07-24SaleVerrica Pharmaceuticals Inc.
VRCA
Chief Legal Officer
33,789
0.0742%
$4.83$163,201+6.65%
2022-07-11PurchaseVerrica Pharmaceuticals Inc.
VRCA
Chief Legal Officer
7,500
0.0215%
$3.40$25,500+44.9%
2022-07-05PurchaseVerrica Pharmaceuticals Inc.
VRCA
Chief Legal Officer
5,714
0.0119%
$2.10$11,999+61.6%
2021-06-04PurchaseVerrica Pharmaceuticals Inc.
VRCA
Chief Legal Officer
2,500
0.0091%
$9.79$24,475+1.07%
Total: 11
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.